The pilot will use a digital health platform, iPostOp™, to monitor surgical patients during their postoperative recovery.
AKRON, OH, March 20, 2019 /24-7PressRelease/ — Jefferson Health, a 14-hospital health system in Pennsylvania and New Jersey, and MegesHealth announced today an agreement to conduct a pilot using MegesHealth’s iPostOp™ digital platform to monitor surgical patients during their postoperative recovery. The platform features a mobile app with a supporting web-enabled application to engage patients primarily after hospital discharge during the critical 30-day period following surgery. Its goal is the early identification of post-surgical complications. iPostOp™ also integrates e-knowledge and fully-encrypted communication engines to improve patients’ health literacy and establish a real-time link between patients and their medical care team outside the boundaries of health care institutions.
The pilot will encompass deploying iPostOp™ to targeted surgical departments at key Jefferson sites, starting with Abington Hospital, and evaluating improvements in both the patient experience and productivity gains in key post-surgical monitoring and patient engagement processes. The objective of the pilot is to field test the platform for a period of 90 days ahead of a potentially wider deployment.
“We are delighted that a leading academic healthcare institution such as Jefferson Health has agreed to engage with us on a pilot of this scale,” said Dr. Georges Markarian, Founder and Chief Medical Officer of MegesHealth. “iPostOp™ has been designed to digitally mirror preoperative and postoperative processes which are critical in delivering an optimal surgical patient experience. It provides a unique engagement platform that enables medical care teams to monitor the recovery of surgical patients and manage complications in a more proactive approach than ever before. Our aim is to streamline and optimize post-surgical follow-up for both patients and surgeons in an effort to optimize patients’ recovery and reduce costly readmissions that impact both patients and healthcare systems. We have achieved this through iPostOp™ and we are excited at the prospect of demonstrating it in partnership with Jefferson Health.”
“Being able to send the right information at the right time is critical in enhancing care levels and recovery in all medical conditions, especially following surgeries regardless of their severity,” said Dr. Edmund Pribitkin, Chief Medical Officer of Thomas Jefferson University Hospitals (TJUH). “At TJUH, we are focused on improving the patient experience especially when challenges are identified. By leveraging, the ‘right-time’ preoperative and postoperative capabilities of iPostOp™, we will be able to better engage our surgical patients from the time their surgery is scheduled until they are cleared by their surgeon during their last post-surgical visit. iPostOp™ gives us precisely the ability to optimize our patient experience and offer us significant productivity improvements and cost-reduction opportunities. We look forward to completing a successful pilot ahead of a production rollout.”
About Jefferson Health
Jefferson Health is reimagining health care in the greater Philadelphia region and southern New Jersey. Our dedicated team of doctors, nurses, health professionals and staff provides a range of primary to highly-specialized care through 14 hospitals (seven Magnet®-designated for nursing excellence), more than 40 outpatient and urgent care locations, the NCI-designated Sidney Kimmel Cancer Center and Magee Rehabilitation. Thomas Jefferson University Hospitals, Inc., is nationally ranked in 10 speciality areas by U.S. News & World Report (2018-19).
MegesHealth designs, develops and operates SaaS digital health platforms targeting distinct medical conditions based on an automated daily patient engagement model coupled with real-time intervention capabilities for medical care teams and institutions. The company is headquartered in Akron, OH. To learn more, visit www.megeshealth.com.
For the original version of this press release, please visit 24-7PressRelease.com here